Evidence map›Paper›PMID 18936968›Full record

ArticleVirchows Archiv : an international journal of pathology2008

Immunophenotyping and oncogene amplifications in tumors of the papilla of Vater.

Daniel Baumhoer, Inti Zlobec, Luigi Tornillo, Wolfgang Dietmaier, Peter H Wuensch, Arndt Hartmann, Fausto Sessa, Petra Ruemmele, Luigi M Terracciano

Abstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Epidermal growth factor receptor signaling pathway is frequently altered in ampullary carcinoma at protein and genetic levels.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Daniel BaumhoerInstitute of Pathology, University of Basel, Schönbeinstrasse 40, 4003 Basel, Switzerland. dbaumhoer@mac.com
Inti Zlobec
Luigi Tornillo
Wolfgang Dietmaier
Peter H Wuensch
Arndt Hartmann
Fausto Sessa
Petra Ruemmele
Luigi M Terracciano
University of Basel · CHUniversity of Regensburg · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DENuremberg Hospital · DEUniversity of Insubria · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carcinomas of the ampulla of Vater are rare and assumed to generally arise from preexisting adenomas (adenoma-carcinoma sequence). Histologically, distinct subtypes can be distinguished that were shown to differ significantly in terms of clinical outcome. Since pathologists usually receive bioptic tissue samples of ampullary tumors obtained during endoscopy, accurate classification of carcinoma subtypes can sometimes be difficult on morphological criteria alone. We therefore performed immunohistochemistry using a panel of established marker proteins (CK7, CK20, p21, p27, ESA, bax, and ephrin-B2) on 175 carcinoma, 111 adenoma, and 152 normal mucosa specimens of the ampulla of Vater and identified distinct immunoprofiles for every carcinoma subtype. Fluorescence in situ hybridization analyses of therapeutic target genes (c-myc, EGFR1, CCND1, HER2) found CCND1 to represent the most frequently amplified gene in our series (7.5%).

Indexed as

AdenomaAdolescentAdultAgedAged, 80 and overAmpulla of Vaterbcl-2-Associated X ProteinBiomarkers, TumorCommon Bile Duct NeoplasmsCyclin D1Ephrin-B2Erb-b2 Receptor Tyrosine KinasesFemaleGene AmplificationGene Expression Regulation, NeoplasticHumansbcl-2-Associated X ProteinBiomarkers, TumorCCND1 protein, humanCyclin D1Ephrin-B2ERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesKeratin-20Keratin-7MYC protein, humanp27 antigenProliferating Cell Nuclear AntigenProto-Oncogene Proteins c-myc

Identifiers

PMID18936968
OpenAlexW2014134263

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.